- Home
- MNY vs GDTC Comparison
MNY vs GDTC Comparison
Compare MNY & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNY
- GDTC
- Stock Information
- Founded
- MNY 2014
- GDTC 2018
- Country
- MNY Singapore
- GDTC Singapore
- Employees
- MNY N/A
- GDTC N/A
- Industry
- MNY
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- MNY
- GDTC Health Care
- Exchange
- MNY Nasdaq
- GDTC Nasdaq
- Market Cap
- MNY 30.4M
- GDTC 29.4M
- IPO Year
- MNY N/A
- GDTC 2023
- Fundamental
- Price
- MNY $0.74
- GDTC $2.46
- Analyst Decision
- MNY
- GDTC Buy
- Analyst Count
- MNY 0
- GDTC 1
- Target Price
- MNY N/A
- GDTC $5.00
- AVG Volume (30 Days)
- MNY 67.2K
- GDTC 32.8K
- Earning Date
- MNY 04-29-2025
- GDTC 01-01-0001
- Dividend Yield
- MNY N/A
- GDTC N/A
- EPS Growth
- MNY N/A
- GDTC N/A
- EPS
- MNY N/A
- GDTC N/A
- Revenue
- MNY $90,185,081.00
- GDTC $330,254.00
- Revenue This Year
- MNY $18.50
- GDTC $14.71
- Revenue Next Year
- MNY $24.83
- GDTC N/A
- P/E Ratio
- MNY N/A
- GDTC N/A
- Revenue Growth
- MNY 24.60
- GDTC N/A
- 52 Week Low
- MNY $0.55
- GDTC $1.20
- 52 Week High
- MNY $2.75
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- MNY 47.32
- GDTC 49.89
- Support Level
- MNY $0.55
- GDTC $2.26
- Resistance Level
- MNY $0.80
- GDTC $2.53
- Average True Range (ATR)
- MNY 0.10
- GDTC 0.25
- MACD
- MNY 0.01
- GDTC 0.01
- Stochastic Oscillator
- MNY 70.26
- GDTC 55.38
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.